Description
More than a billion doses of covid-19 vaccine have been made. Now comes the hard part: ensuring every country in the world has access to them. Can distribution be made more equitable?
Alok Jha and Natasha Loder are joined by Edward Carr, The Economist’s deputy editor, and Sondre Solstad, senior data journalist.
With Seth Berkley of GAVI, the Vaccine Alliance, and John Nkengasong, director of the Africa Centres for Disease Control and Prevention.
For full access to The Economist’s print, digital and audio editions subscribe at economist.com/thejabpod. Sign up for our new weekly science and data newsletters at economist.com/simplyscience and economist.com/offthecharts
See acast.com/privacy for privacy and opt-out information.
Vaccines are helping some countries return to a semblance of normalcy, while much of the world remains vulnerable to covid-19. We explore what’s next for the pandemic at this critical juncture. Soumya Swaminathan, Chief Scientist at the World Health Organisation, says solidarity has been lacking...
Published 06/28/21
The first covid-19 vaccines came from rapid innovation. They have already saved millions of lives. What new technologies are in the pipeline?
Robin Shattock’s team at Imperial College London is developing a self-amplifying RNA vaccine.
Moz Siddiqui of Gavi, the Vaccine Alliance, describes a...
Published 06/21/21